Regular Article
Protection against Acetaminophen Toxicity in CYP1A2 and CYP2E1 Double-Null Mice

https://doi.org/10.1006/taap.1998.8501Get rights and content

Abstract

Acetaminophen (APAP) hepatotoxicity is due to its biotransformation to a reactive metabolite,N-acetyl-p-benzoquinone imine (NAPQI), that is capable of binding to cellular macromolecules. At least two forms of cytochrome P450, CYP2E1 and CYP1A2, have been implicated in this reaction in mice. To test the combined roles of CYP1A2 and CYP2E1 in an intact animal model, a double-null mouse line lacking functional expression of CYP1A2 and CYP2E1 was produced by cross-breedingCyp1a2−/− mice withCyp2e1−/− mice. Animals deficient in the expression of both P450s developed normally and exhibited no obvious phenotypic abnormalities. Comparison of the dose–response to APAP (200–1200 mg/kg) indicated that double-null animals were highly resistant to APAP-induced toxicity whereas the wild-type animals were sensitive. Administration of 600 to 800 mg/kg of this drug to male wild-type animals resulted in increased plasma concentrations of liver enzymes (alanine aminotransferase, sorbitol dehydrogenase), lipidosis, hepatic necrosis, and renal tubular necrosis. In contrast, when APAP of equivalent or higher dose was administered to the double-null mice, plasma levels of liver enzymes and liver histopathology were normal. However, administration of 1200 mg of APAP/kg to the double-null mice resulted in infrequent liver lipidosis and mild kidney lesions. Consistent with the protection from hepatotoxicity, the expected depletion of hepatic glutathione (GSH) content was significantly retarded and APAP covalent binding to hepatic cytosolic proteins was not detectable in the double-null mice. Likewise,in vitroactivation of APAP by liver microsomes from the double-null mice was approximately one tenth of that in microsomes from wild-type mice. Thus, the protection against APAP toxicity afforded by deletion of both CYP2E1 and CYP1A2 likely reflects greatly diminished production of the toxic electrophile, NAPQI.

References (40)

  • K.E. Thummel et al.

    Oxidation of acetaminophen toNp

    Biochem. Pharmacol.

    (1993)
  • J.A. Vale et al.

    Paracetamol (acetaminophen) poisoning

    Lancet

    (1995)
  • J.B. Bartolone et al.

    Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins

    Biochem. Pharmacol.

    (1988)
  • W.P. Beierschmitt et al.

    Age-related changes in renal metabolism of acetaminophen in male Fisher 344 rats

    Age

    (1986)
  • M. Black

    Acetaminophen hepatotoxicity

    Annu. Rev. Med.

    (1984)
  • R.F. Burk et al.

    Isoniazid potentiation of acetaminophen hepatotoxicity in the rat and 4-methylpyrazole inhibition of it

    Res. Commun. Chem. Pathol. Pharmacol.

    (1990)
  • S.D. Cohen et al.

    Selective protein covalent binding and acetaminophen-induced hepatotoxicity

    Drug Metab. Rev.

    (1997)
  • S.G. Emeigh Hart et al.

    Acetaminophen nephrotoxicity in CD-1 mice. I. Evidence of a role forin situ

    Toxicol. Appl. Pharmacol.

    (1994)
  • S.G. Emeigh Hart et al.

    In vivoin vitroin situ

    Biological Reactive Intermediates IV

    (1990)
  • Cited by (0)

    C. M. Winter

    1

    Present address: Institut fur Unwelthygiene und Toxicologie, Technische Universitat, München, Lazarettstrasse 62, D-8000, München 19, Germany.

    View full text